Aims Topical ciclosporin A (CsA) is a therapeutic option for dry eye disease (DED) to control ocular surface inflammation and improve tear function. The aim of this study is to systematically review ...

This positions Tixel i as a safe, non-pharmacologic, first-line treatment for Meibomian Gland Dysfunction (MGD) (Sanni, Koloms, Case, & Bailey, 2025). A practice-ready solution ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content. For more information on individual ...

HHS secretary Robert F. Kennedy Jr. declared that the FDA’s “suppression of psychedelics” was about to end. Now he and his allies may be in position to do something about it.

Our late‑stage product candidates are reproxalap, a RASP modulator for the potential treatment of dry eye disease and allergic conjunctivitis, and ADX‑2191, a novel formulation of intravitreal ...

The global Eye Infections Treatment Market is projected to be valued at USD 8,160.6 million in 2025, reaching USD 11,400.7 million by 2035, with a compound annual growth rate (CAGR) of 4.7% during the ...

Eye conditions can also pose safety risks, such as an increased likelihood of falls or accidents. Additionally, eye exams can sometimes reveal other underlying health conditions. These include issues ...

Without treatment, these infections can lead to eye pain, vision problems, and in some cases, blindness. Parasites are organisms that live in, or on, another organism.

Dr. Steven Sarkisian leads Oklahoma Eye Surgeons in cutting-edge treatments like MIGS and robotic cataract surgery, restoring vision across the state.